| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 28 | 2024 | 1292 | 4.220 |
Why?
|
| Premature Birth | 20 | 2024 | 1771 | 2.350 |
Why?
|
| Gynecologic Surgical Procedures | 14 | 2021 | 304 | 2.070 |
Why?
|
| Pregnancy Rate | 15 | 2021 | 649 | 2.060 |
Why?
|
| Pregnancy | 146 | 2024 | 29749 | 2.000 |
Why?
|
| Pregnancy Outcome | 29 | 2024 | 2907 | 1.980 |
Why?
|
| Live Birth | 14 | 2023 | 512 | 1.800 |
Why?
|
| Abortion, Induced | 6 | 2022 | 460 | 1.740 |
Why?
|
| Embryo Transfer | 11 | 2024 | 522 | 1.610 |
Why?
|
| Infertility | 15 | 2023 | 655 | 1.560 |
Why?
|
| Obstetrics | 14 | 2022 | 667 | 1.530 |
Why?
|
| Placenta Diseases | 4 | 2022 | 196 | 1.520 |
Why?
|
| Placenta Accreta | 5 | 2022 | 237 | 1.490 |
Why?
|
| Placenta | 11 | 2023 | 1702 | 1.480 |
Why?
|
| Gynecology | 11 | 2022 | 528 | 1.390 |
Why?
|
| Pelvic Organ Prolapse | 12 | 2022 | 119 | 1.380 |
Why?
|
| Preimplantation Diagnosis | 5 | 2023 | 143 | 1.190 |
Why?
|
| Genital Neoplasms, Female | 6 | 2024 | 533 | 1.180 |
Why?
|
| Cervix Uteri | 8 | 2024 | 582 | 1.090 |
Why?
|
| Abortion, Legal | 2 | 2018 | 114 | 1.060 |
Why?
|
| Maternal Age | 8 | 2022 | 807 | 1.000 |
Why?
|
| Hemophilia A | 6 | 2007 | 359 | 0.900 |
Why?
|
| Female | 235 | 2024 | 391270 | 0.880 |
Why?
|
| Costs and Cost Analysis | 2 | 2021 | 1677 | 0.850 |
Why?
|
| Delivery, Obstetric | 12 | 2021 | 932 | 0.830 |
Why?
|
| Oocyte Donation | 2 | 2019 | 52 | 0.810 |
Why?
|
| Gestational Age | 16 | 2024 | 3565 | 0.810 |
Why?
|
| Cesarean Section | 9 | 2022 | 1385 | 0.780 |
Why?
|
| Postpartum Hemorrhage | 3 | 2019 | 265 | 0.760 |
Why?
|
| Suburethral Slings | 8 | 2020 | 72 | 0.760 |
Why?
|
| Insurance | 1 | 2022 | 114 | 0.740 |
Why?
|
| Placenta Previa | 2 | 2019 | 122 | 0.730 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2023 | 384 | 0.720 |
Why?
|
| Pelvic Floor | 6 | 2021 | 138 | 0.700 |
Why?
|
| Contraception Behavior | 4 | 2014 | 180 | 0.700 |
Why?
|
| Birth Rate | 7 | 2020 | 168 | 0.700 |
Why?
|
| Ultrasonography, Prenatal | 7 | 2023 | 1745 | 0.680 |
Why?
|
| Pre-Eclampsia | 10 | 2023 | 1229 | 0.680 |
Why?
|
| Humans | 258 | 2024 | 760621 | 0.680 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2023 | 497 | 0.670 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2023 | 2003 | 0.660 |
Why?
|
| Pain, Postoperative | 7 | 2023 | 1721 | 0.650 |
Why?
|
| Infant, Low Birth Weight | 5 | 2023 | 859 | 0.640 |
Why?
|
| Marijuana Smoking | 1 | 2022 | 257 | 0.620 |
Why?
|
| Government Regulation | 2 | 2013 | 525 | 0.620 |
Why?
|
| Pregnant Women | 2 | 2021 | 563 | 0.620 |
Why?
|
| Counseling | 6 | 2023 | 1548 | 0.610 |
Why?
|
| Adult | 130 | 2024 | 219994 | 0.610 |
Why?
|
| Infant, Newborn | 42 | 2024 | 26181 | 0.590 |
Why?
|
| Blastocyst | 6 | 2020 | 433 | 0.590 |
Why?
|
| Abortion, Spontaneous | 5 | 2023 | 530 | 0.580 |
Why?
|
| Contraception | 4 | 2016 | 349 | 0.570 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2017 | 26 | 0.560 |
Why?
|
| Intrauterine Devices, Copper | 1 | 2017 | 30 | 0.560 |
Why?
|
| Levonorgestrel | 1 | 2017 | 74 | 0.550 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 3986 | 0.550 |
Why?
|
| Research Report | 1 | 2020 | 370 | 0.540 |
Why?
|
| Retrospective Studies | 68 | 2024 | 80372 | 0.540 |
Why?
|
| Ischemia | 3 | 2020 | 1893 | 0.540 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3763 | 0.540 |
Why?
|
| Patient Dropouts | 1 | 2018 | 412 | 0.540 |
Why?
|
| Infant Mortality | 3 | 2019 | 757 | 0.530 |
Why?
|
| Multiple Birth Offspring | 2 | 2012 | 22 | 0.530 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 1607 | 0.530 |
Why?
|
| Patient Simulation | 4 | 2012 | 297 | 0.530 |
Why?
|
| Community Health Centers | 4 | 2017 | 453 | 0.510 |
Why?
|
| Urination Disorders | 4 | 2020 | 240 | 0.510 |
Why?
|
| Pregnancy, Unwanted | 2 | 2014 | 24 | 0.510 |
Why?
|
| Cannabis | 1 | 2022 | 436 | 0.510 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 5397 | 0.500 |
Why?
|
| After-Hours Care | 1 | 2016 | 102 | 0.490 |
Why?
|
| Congresses as Topic | 1 | 2020 | 805 | 0.480 |
Why?
|
| Patient Care Team | 4 | 2020 | 2511 | 0.480 |
Why?
|
| Streptococcus agalactiae | 2 | 2019 | 337 | 0.480 |
Why?
|
| Endometrium | 1 | 2017 | 403 | 0.470 |
Why?
|
| Patient Satisfaction | 7 | 2022 | 3448 | 0.460 |
Why?
|
| Air Pollutants | 6 | 2024 | 2844 | 0.460 |
Why?
|
| Obstetric Labor Complications | 2 | 2017 | 236 | 0.460 |
Why?
|
| Health Personnel | 4 | 2016 | 3310 | 0.460 |
Why?
|
| Pregnancy Complications | 12 | 2024 | 2942 | 0.450 |
Why?
|
| Health Status Disparities | 4 | 2019 | 1830 | 0.440 |
Why?
|
| Leadership | 3 | 2017 | 1371 | 0.430 |
Why?
|
| Maternal Exposure | 8 | 2024 | 1045 | 0.430 |
Why?
|
| Molecular Imaging | 1 | 2020 | 818 | 0.420 |
Why?
|
| Progesterone | 3 | 2024 | 742 | 0.410 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 498 | 0.400 |
Why?
|
| Aneuploidy | 6 | 2023 | 551 | 0.400 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 143 | 0.400 |
Why?
|
| Streptococcal Infections | 2 | 2019 | 617 | 0.390 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 704 | 0.390 |
Why?
|
| Cardiotocography | 1 | 2011 | 24 | 0.380 |
Why?
|
| Prenatal Care | 4 | 2024 | 1129 | 0.380 |
Why?
|
| United States | 32 | 2024 | 72461 | 0.380 |
Why?
|
| Cross-Sectional Studies | 28 | 2024 | 25942 | 0.380 |
Why?
|
| Cosmetics | 2 | 2023 | 102 | 0.380 |
Why?
|
| Heart Rate, Fetal | 1 | 2011 | 75 | 0.380 |
Why?
|
| Urinary Incontinence, Stress | 4 | 2016 | 181 | 0.380 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2023 | 114 | 0.380 |
Why?
|
| Pregnancy, Multiple | 3 | 2022 | 215 | 0.370 |
Why?
|
| Stress, Psychological | 5 | 2019 | 4446 | 0.370 |
Why?
|
| Depression | 6 | 2023 | 8044 | 0.370 |
Why?
|
| Internet | 3 | 2022 | 3078 | 0.370 |
Why?
|
| Knowledge | 1 | 2012 | 176 | 0.360 |
Why?
|
| Hemarthrosis | 2 | 2007 | 39 | 0.350 |
Why?
|
| Ambulatory Care | 3 | 2020 | 2781 | 0.350 |
Why?
|
| Social Class | 3 | 2018 | 2005 | 0.350 |
Why?
|
| Clinical Competence | 8 | 2022 | 4783 | 0.340 |
Why?
|
| Hypotension | 1 | 2016 | 883 | 0.340 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2019 | 460 | 0.340 |
Why?
|
| Infertility, Female | 4 | 2021 | 759 | 0.340 |
Why?
|
| Urination | 3 | 2016 | 202 | 0.340 |
Why?
|
| Urinary Incontinence | 5 | 2019 | 495 | 0.340 |
Why?
|
| Income | 2 | 2019 | 1875 | 0.340 |
Why?
|
| Reproductive Medicine | 2 | 2022 | 100 | 0.340 |
Why?
|
| MicroRNAs | 2 | 2022 | 3790 | 0.330 |
Why?
|
| Boston | 15 | 2024 | 9280 | 0.330 |
Why?
|
| Referral and Consultation | 4 | 2024 | 3598 | 0.330 |
Why?
|
| Environmental Exposure | 4 | 2024 | 4412 | 0.330 |
Why?
|
| Laparoscopy | 8 | 2021 | 2147 | 0.320 |
Why?
|
| Birth Weight | 9 | 2023 | 2097 | 0.320 |
Why?
|
| Cohort Studies | 28 | 2024 | 41335 | 0.320 |
Why?
|
| Birth Order | 2 | 2019 | 95 | 0.320 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2016 | 732 | 0.310 |
Why?
|
| Young Adult | 39 | 2024 | 58741 | 0.310 |
Why?
|
| Cervical Length Measurement | 3 | 2024 | 45 | 0.310 |
Why?
|
| Food Supply | 2 | 2024 | 542 | 0.310 |
Why?
|
| Hysterectomy | 5 | 2019 | 904 | 0.310 |
Why?
|
| Ovulation Induction | 5 | 2021 | 277 | 0.300 |
Why?
|
| Prospective Studies | 29 | 2024 | 54303 | 0.300 |
Why?
|
| Placentation | 2 | 2019 | 78 | 0.300 |
Why?
|
| Prenatal Diagnosis | 4 | 2020 | 1264 | 0.300 |
Why?
|
| Mothers | 7 | 2020 | 2186 | 0.300 |
Why?
|
| Uterine Prolapse | 2 | 2021 | 68 | 0.290 |
Why?
|
| Fetal Development | 5 | 2023 | 766 | 0.290 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2754 | 0.280 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2024 | 83 | 0.280 |
Why?
|
| Obstetric Labor, Premature | 2 | 2019 | 274 | 0.280 |
Why?
|
| Attitude to Health | 4 | 2018 | 2029 | 0.280 |
Why?
|
| Myofascial Pain Syndromes | 2 | 2019 | 37 | 0.280 |
Why?
|
| Attitude of Health Personnel | 4 | 2020 | 3865 | 0.270 |
Why?
|
| Directive Counseling | 3 | 2020 | 171 | 0.270 |
Why?
|
| Solar Activity | 2 | 2023 | 44 | 0.270 |
Why?
|
| Fertility | 5 | 2023 | 773 | 0.260 |
Why?
|
| Equipment Contamination | 1 | 2007 | 179 | 0.260 |
Why?
|
| Air Pollution | 3 | 2024 | 2317 | 0.260 |
Why?
|
| Middle Aged | 58 | 2024 | 220352 | 0.250 |
Why?
|
| Hemophilia B | 1 | 2006 | 84 | 0.250 |
Why?
|
| Particulate Matter | 5 | 2024 | 2559 | 0.250 |
Why?
|
| Cost of Illness | 5 | 2024 | 1940 | 0.250 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 4371 | 0.250 |
Why?
|
| Lead | 2 | 2022 | 880 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2020 | 558 | 0.250 |
Why?
|
| Teaching | 2 | 2015 | 1169 | 0.250 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 582 | 0.250 |
Why?
|
| Joints | 1 | 2007 | 321 | 0.250 |
Why?
|
| Ploidies | 3 | 2010 | 275 | 0.250 |
Why?
|
| Diabetes, Gestational | 3 | 2021 | 1242 | 0.240 |
Why?
|
| Botswana | 3 | 2023 | 1040 | 0.240 |
Why?
|
| Students, Medical | 2 | 2023 | 1927 | 0.240 |
Why?
|
| Cisplatin | 3 | 2020 | 1644 | 0.240 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2023 | 2496 | 0.240 |
Why?
|
| Health Care Surveys | 3 | 2013 | 2435 | 0.240 |
Why?
|
| Mass Screening | 7 | 2022 | 5423 | 0.230 |
Why?
|
| Pelvic Pain | 2 | 2019 | 298 | 0.230 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 4013 | 0.230 |
Why?
|
| Parity | 4 | 2022 | 925 | 0.230 |
Why?
|
| Fetal Blood | 3 | 2021 | 1343 | 0.230 |
Why?
|
| Prevalence | 11 | 2023 | 15687 | 0.230 |
Why?
|
| Hospitalization | 4 | 2021 | 10790 | 0.230 |
Why?
|
| Acetic Acid | 1 | 2023 | 60 | 0.230 |
Why?
|
| Postpartum Period | 4 | 2024 | 1167 | 0.230 |
Why?
|
| Cerclage, Cervical | 1 | 2024 | 39 | 0.230 |
Why?
|
| House Calls | 2 | 2022 | 160 | 0.220 |
Why?
|
| Massachusetts | 11 | 2024 | 8803 | 0.220 |
Why?
|
| Quality Improvement | 5 | 2019 | 3836 | 0.220 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2019 | 229 | 0.220 |
Why?
|
| Critical Illness | 1 | 2016 | 2709 | 0.210 |
Why?
|
| Family Planning Services | 3 | 2014 | 265 | 0.210 |
Why?
|
| Colposcopy | 1 | 2023 | 150 | 0.210 |
Why?
|
| Infant | 16 | 2024 | 36060 | 0.210 |
Why?
|
| Case-Control Studies | 16 | 2022 | 22053 | 0.210 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 926 | 0.210 |
Why?
|
| Placental Circulation | 2 | 2020 | 37 | 0.210 |
Why?
|
| Environmental Pollutants | 2 | 2022 | 1266 | 0.210 |
Why?
|
| Odds Ratio | 6 | 2018 | 9716 | 0.210 |
Why?
|
| Social Stigma | 3 | 2019 | 734 | 0.210 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3736 | 0.200 |
Why?
|
| Endometrial Hyperplasia | 1 | 2023 | 97 | 0.200 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 526 | 0.200 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2024 | 189 | 0.200 |
Why?
|
| Treatment Outcome | 25 | 2021 | 65017 | 0.200 |
Why?
|
| Vagina | 4 | 2022 | 837 | 0.200 |
Why?
|
| Progestins | 1 | 2024 | 302 | 0.200 |
Why?
|
| Anxiety | 5 | 2023 | 4538 | 0.200 |
Why?
|
| Vaginal Neoplasms | 1 | 2022 | 104 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2021 | 2125 | 0.200 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2019 | 518 | 0.200 |
Why?
|
| Dystocia | 2 | 2012 | 33 | 0.200 |
Why?
|
| Endocrine Disruptors | 2 | 2024 | 263 | 0.200 |
Why?
|
| Surgical Instruments | 2 | 2018 | 385 | 0.190 |
Why?
|
| Internship and Residency | 5 | 2022 | 5870 | 0.190 |
Why?
|
| Oils | 1 | 2021 | 56 | 0.190 |
Why?
|
| Hair Preparations | 1 | 2021 | 32 | 0.190 |
Why?
|
| Genetic Testing | 6 | 2023 | 3531 | 0.190 |
Why?
|
| Resilience, Psychological | 2 | 2020 | 768 | 0.190 |
Why?
|
| Pilot Projects | 10 | 2024 | 8555 | 0.190 |
Why?
|
| Sepsis | 2 | 2014 | 2592 | 0.190 |
Why?
|
| Insurance, Health | 4 | 2022 | 2501 | 0.190 |
Why?
|
| Search Engine | 1 | 2022 | 140 | 0.190 |
Why?
|
| Cryopreservation | 3 | 2020 | 717 | 0.190 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 184 | 0.180 |
Why?
|
| Micronutrients | 1 | 2024 | 381 | 0.180 |
Why?
|
| Education, Medical | 2 | 2012 | 1727 | 0.180 |
Why?
|
| Incidence | 12 | 2021 | 21392 | 0.180 |
Why?
|
| Faculty, Medical | 3 | 2020 | 1192 | 0.180 |
Why?
|
| Physical Examination | 1 | 2007 | 1244 | 0.180 |
Why?
|
| Urinary Catheterization | 2 | 2019 | 198 | 0.180 |
Why?
|
| Informed Consent | 2 | 2020 | 1005 | 0.180 |
Why?
|
| Embryo Implantation | 3 | 2013 | 270 | 0.180 |
Why?
|
| Physician-Patient Relations | 2 | 2024 | 3242 | 0.180 |
Why?
|
| Teaching Materials | 1 | 2020 | 84 | 0.180 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3202 | 0.180 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2021 | 137 | 0.180 |
Why?
|
| Nuclear Medicine | 2 | 2020 | 236 | 0.180 |
Why?
|
| DNA Methylation | 3 | 2020 | 4373 | 0.180 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2024 | 357 | 0.180 |
Why?
|
| Placental Insufficiency | 1 | 2020 | 50 | 0.180 |
Why?
|
| Anal Canal | 2 | 2021 | 372 | 0.170 |
Why?
|
| Labor, Induced | 2 | 2018 | 151 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2024 | 3106 | 0.170 |
Why?
|
| Health Policy | 3 | 2022 | 2677 | 0.170 |
Why?
|
| Infection Control | 1 | 2007 | 983 | 0.170 |
Why?
|
| Audiovisual Aids | 1 | 2020 | 99 | 0.170 |
Why?
|
| Shoulder | 2 | 2012 | 299 | 0.170 |
Why?
|
| Blood Coagulation Factors | 2 | 2001 | 365 | 0.170 |
Why?
|
| Radioactivity | 1 | 2020 | 58 | 0.170 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2019 | 28 | 0.170 |
Why?
|
| Phyllodes Tumor | 1 | 2019 | 52 | 0.170 |
Why?
|
| Austria | 1 | 2020 | 206 | 0.170 |
Why?
|
| Colitis, Ulcerative | 3 | 2017 | 1919 | 0.170 |
Why?
|
| Time Factors | 14 | 2021 | 40165 | 0.170 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 131 | 0.170 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2019 | 28 | 0.170 |
Why?
|
| Health Expenditures | 3 | 2023 | 2362 | 0.170 |
Why?
|
| Male | 49 | 2024 | 359744 | 0.170 |
Why?
|
| Reproductive History | 1 | 2020 | 210 | 0.170 |
Why?
|
| Uterine Neoplasms | 2 | 2020 | 1439 | 0.170 |
Why?
|
| Triage | 2 | 2023 | 987 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2021 | 465 | 0.160 |
Why?
|
| International Agencies | 1 | 2020 | 244 | 0.160 |
Why?
|
| Urinary Retention | 3 | 2019 | 106 | 0.160 |
Why?
|
| HIV | 2 | 2023 | 1579 | 0.160 |
Why?
|
| Pericytes | 1 | 2021 | 293 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 296 | 0.160 |
Why?
|
| Human papillomavirus 18 | 1 | 2019 | 125 | 0.160 |
Why?
|
| Birth Intervals | 1 | 2018 | 51 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 278 | 0.160 |
Why?
|
| Guideline Adherence | 3 | 2019 | 2283 | 0.160 |
Why?
|
| Age Factors | 10 | 2019 | 18416 | 0.160 |
Why?
|
| Language | 3 | 2024 | 1533 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2020 | 748 | 0.150 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3085 | 0.150 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 218 | 0.150 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 529 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3205 | 0.150 |
Why?
|
| Policy | 1 | 2022 | 511 | 0.150 |
Why?
|
| Oocytes | 2 | 2022 | 1165 | 0.150 |
Why?
|
| Blood Glucose | 4 | 2024 | 6381 | 0.150 |
Why?
|
| Lymphopenia | 1 | 2020 | 280 | 0.150 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3143 | 0.150 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2016 | 156 | 0.150 |
Why?
|
| Reproductive Health Services | 1 | 2019 | 87 | 0.150 |
Why?
|
| Abdomen | 2 | 2014 | 1130 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 258 | 0.150 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 377 | 0.150 |
Why?
|
| Fellowships and Scholarships | 2 | 2018 | 1116 | 0.150 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2017 | 4 | 0.150 |
Why?
|
| Human papillomavirus 16 | 1 | 2019 | 265 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2012 | 516 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 416 | 0.150 |
Why?
|
| Cyclophosphamide | 2 | 2020 | 2221 | 0.140 |
Why?
|
| Injections | 2 | 2019 | 830 | 0.140 |
Why?
|
| Radionuclide Imaging | 2 | 2020 | 1975 | 0.140 |
Why?
|
| Nurse Practitioners | 2 | 2017 | 268 | 0.140 |
Why?
|
| Body Mass Index | 6 | 2024 | 12914 | 0.140 |
Why?
|
| Phthalic Acids | 1 | 2022 | 476 | 0.140 |
Why?
|
| Critical Pathways | 1 | 2021 | 475 | 0.140 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 361 | 0.140 |
Why?
|
| Single Embryo Transfer | 1 | 2016 | 29 | 0.140 |
Why?
|
| Hypercalcemia | 1 | 2020 | 421 | 0.140 |
Why?
|
| Patient Preference | 1 | 2024 | 922 | 0.140 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 796 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2021 | 15697 | 0.140 |
Why?
|
| Milk, Human | 1 | 2021 | 483 | 0.140 |
Why?
|
| Citric Acid | 1 | 2017 | 123 | 0.140 |
Why?
|
| Hot Temperature | 1 | 2023 | 1435 | 0.140 |
Why?
|
| Embryonic Development | 3 | 2010 | 716 | 0.140 |
Why?
|
| Financing, Personal | 1 | 2019 | 309 | 0.140 |
Why?
|
| Pessaries | 1 | 2016 | 15 | 0.140 |
Why?
|
| Sex Reassignment Surgery | 1 | 2019 | 156 | 0.140 |
Why?
|
| Doxorubicin | 2 | 2020 | 2209 | 0.140 |
Why?
|
| Exercise Therapy | 2 | 2021 | 919 | 0.130 |
Why?
|
| Colorado | 2 | 2007 | 164 | 0.130 |
Why?
|
| Enema | 1 | 2017 | 141 | 0.130 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 405 | 0.130 |
Why?
|
| Intrauterine Devices | 1 | 2017 | 114 | 0.130 |
Why?
|
| Neuromuscular Agents | 2 | 2019 | 148 | 0.130 |
Why?
|
| Fibrinogen | 1 | 2019 | 886 | 0.130 |
Why?
|
| Quinolines | 1 | 2021 | 759 | 0.130 |
Why?
|
| Psychometrics | 1 | 2006 | 3051 | 0.130 |
Why?
|
| Nicotine | 1 | 2021 | 677 | 0.130 |
Why?
|
| Communication | 4 | 2023 | 3849 | 0.130 |
Why?
|
| Cities | 1 | 2018 | 538 | 0.130 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 273 | 0.130 |
Why?
|
| Insurance Coverage | 3 | 2023 | 1939 | 0.130 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2017 | 93 | 0.130 |
Why?
|
| Scopolamine | 1 | 2016 | 94 | 0.130 |
Why?
|
| Postnatal Care | 2 | 2020 | 260 | 0.130 |
Why?
|
| Urinary Tract Infections | 2 | 2019 | 814 | 0.130 |
Why?
|
| Residence Characteristics | 3 | 2024 | 2062 | 0.130 |
Why?
|
| Telephone | 1 | 2019 | 624 | 0.130 |
Why?
|
| Coercion | 1 | 2016 | 69 | 0.130 |
Why?
|
| Antioxidants | 1 | 2024 | 1667 | 0.130 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 643 | 0.130 |
Why?
|
| Cathartics | 1 | 2017 | 127 | 0.130 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 352 | 0.130 |
Why?
|
| Protein C | 2 | 2008 | 133 | 0.130 |
Why?
|
| Telomere | 2 | 2018 | 933 | 0.130 |
Why?
|
| Muscarinic Antagonists | 1 | 2016 | 138 | 0.130 |
Why?
|
| Infant, Premature | 2 | 2022 | 2092 | 0.130 |
Why?
|
| Physicians | 4 | 2016 | 4591 | 0.130 |
Why?
|
| Vaginal Smears | 2 | 2015 | 495 | 0.130 |
Why?
|
| Urology | 1 | 2020 | 423 | 0.120 |
Why?
|
| Urinary Bladder Diseases | 1 | 2016 | 169 | 0.120 |
Why?
|
| Chorionic Gonadotropin | 1 | 2017 | 457 | 0.120 |
Why?
|
| Nitrogen Dioxide | 3 | 2023 | 512 | 0.120 |
Why?
|
| Risk Management | 1 | 2018 | 558 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2018 | 430 | 0.120 |
Why?
|
| BCG Vaccine | 1 | 2017 | 371 | 0.120 |
Why?
|
| Psychotropic Drugs | 1 | 2020 | 883 | 0.120 |
Why?
|
| Family Practice | 1 | 2017 | 510 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1827 | 0.120 |
Why?
|
| Office Visits | 1 | 2019 | 597 | 0.120 |
Why?
|
| Risk Factors | 19 | 2022 | 74359 | 0.120 |
Why?
|
| Sex Offenses | 2 | 2015 | 351 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2020 | 854 | 0.120 |
Why?
|
| Clomiphene | 1 | 2014 | 71 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 758 | 0.120 |
Why?
|
| Rape | 1 | 2015 | 130 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3758 | 0.120 |
Why?
|
| Subcutaneous Tissue | 1 | 2014 | 132 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 643 | 0.110 |
Why?
|
| Hospitals | 3 | 2017 | 3928 | 0.110 |
Why?
|
| Depression, Postpartum | 2 | 2009 | 345 | 0.110 |
Why?
|
| Fertility Agents, Female | 1 | 2014 | 101 | 0.110 |
Why?
|
| Emotions | 2 | 2023 | 2734 | 0.110 |
Why?
|
| Parental Notification | 1 | 2013 | 12 | 0.110 |
Why?
|
| Adolescent | 19 | 2024 | 87810 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2018 | 613 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 539 | 0.110 |
Why?
|
| Crohn Disease | 2 | 2017 | 2275 | 0.110 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1357 | 0.110 |
Why?
|
| Insemination, Artificial | 1 | 2014 | 99 | 0.110 |
Why?
|
| Mycoplasma genitalium | 1 | 2013 | 12 | 0.110 |
Why?
|
| Lymph Node Excision | 2 | 2018 | 1303 | 0.110 |
Why?
|
| Colonic Pouches | 1 | 2014 | 122 | 0.110 |
Why?
|
| Stillbirth | 1 | 2016 | 368 | 0.110 |
Why?
|
| Civil Rights | 1 | 2014 | 131 | 0.110 |
Why?
|
| Glucose Tolerance Test | 3 | 2024 | 1175 | 0.110 |
Why?
|
| Third-Party Consent | 1 | 2013 | 66 | 0.110 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39261 | 0.110 |
Why?
|
| Sex Factors | 6 | 2018 | 10547 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2016 | 2688 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2020 | 1398 | 0.110 |
Why?
|
| Mycoplasma Infections | 1 | 2013 | 120 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12293 | 0.110 |
Why?
|
| Video Recording | 1 | 2018 | 955 | 0.110 |
Why?
|
| Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
| Phosphates | 1 | 2017 | 772 | 0.110 |
Why?
|
| Postoperative Period | 4 | 2020 | 1818 | 0.110 |
Why?
|
| Abortion Applicants | 1 | 2012 | 5 | 0.110 |
Why?
|
| Antithrombins | 2 | 2008 | 313 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 662 | 0.110 |
Why?
|
| Religion | 1 | 2016 | 376 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2017 | 3442 | 0.110 |
Why?
|
| Longitudinal Ligaments | 1 | 2012 | 25 | 0.110 |
Why?
|
| Pelvis | 1 | 2017 | 743 | 0.110 |
Why?
|
| Propensity Score | 1 | 2020 | 1928 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 708 | 0.100 |
Why?
|
| Data Collection | 3 | 2023 | 3315 | 0.100 |
Why?
|
| Housing | 1 | 2017 | 665 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2020 | 1037 | 0.100 |
Why?
|
| Pain, Intractable | 1 | 2013 | 132 | 0.100 |
Why?
|
| Quality of Health Care | 2 | 2016 | 4360 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 858 | 0.100 |
Why?
|
| Obesity | 4 | 2024 | 12922 | 0.100 |
Why?
|
| Infertility, Male | 1 | 2015 | 396 | 0.100 |
Why?
|
| Labor, Obstetric | 2 | 2016 | 321 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2019 | 9276 | 0.100 |
Why?
|
| Myometrium | 1 | 2013 | 176 | 0.100 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 300 | 0.100 |
Why?
|
| Sex Counseling | 1 | 2011 | 17 | 0.100 |
Why?
|
| Aged | 24 | 2024 | 169152 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2020 | 5075 | 0.100 |
Why?
|
| Cholinergic Antagonists | 2 | 2023 | 164 | 0.100 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1952 | 0.100 |
Why?
|
| Umbilical Cord | 1 | 2013 | 181 | 0.100 |
Why?
|
| Labor Stage, Second | 1 | 2012 | 37 | 0.100 |
Why?
|
| Perinatology | 1 | 2012 | 62 | 0.100 |
Why?
|
| Public Health Practice | 1 | 2014 | 218 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 2 | 2020 | 2821 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 3164 | 0.100 |
Why?
|
| Urban Population | 3 | 2017 | 2022 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 536 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 833 | 0.100 |
Why?
|
| Single-Blind Method | 4 | 2018 | 1578 | 0.100 |
Why?
|
| South Carolina | 2 | 2022 | 100 | 0.100 |
Why?
|
| Fetal Death | 3 | 2020 | 434 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 1841 | 0.100 |
Why?
|
| Echocardiography | 2 | 2015 | 4981 | 0.100 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 222 | 0.090 |
Why?
|
| Urologic Surgical Procedures | 1 | 2014 | 309 | 0.090 |
Why?
|
| Electronic Mail | 1 | 2013 | 213 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 21025 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2024 | 3392 | 0.090 |
Why?
|
| Sex Preselection | 1 | 2010 | 16 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 22072 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 12960 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2018 | 1803 | 0.090 |
Why?
|
| Administration, Intravaginal | 2 | 2024 | 151 | 0.090 |
Why?
|
| Attitude | 1 | 2015 | 777 | 0.090 |
Why?
|
| Defecation | 1 | 2012 | 190 | 0.090 |
Why?
|
| Self Care | 1 | 2015 | 793 | 0.090 |
Why?
|
| Peritoneum | 1 | 2011 | 224 | 0.090 |
Why?
|
| Videotape Recording | 1 | 2012 | 337 | 0.090 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 279 | 0.090 |
Why?
|
| Embryo Culture Techniques | 1 | 2010 | 84 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2017 | 2913 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 2016 | 1166 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2560 | 0.080 |
Why?
|
| Parenting | 1 | 2015 | 695 | 0.080 |
Why?
|
| Child | 14 | 2024 | 79806 | 0.080 |
Why?
|
| Fecal Incontinence | 3 | 2019 | 241 | 0.080 |
Why?
|
| Thigh | 1 | 2010 | 240 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 4878 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2021 | 1724 | 0.080 |
Why?
|
| Estrogens | 1 | 2016 | 1520 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2015 | 761 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 251 | 0.080 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 617 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2013 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 330 | 0.080 |
Why?
|
| Sarcoma | 1 | 2020 | 1786 | 0.080 |
Why?
|
| Follicular Fluid | 1 | 2009 | 92 | 0.080 |
Why?
|
| Child, Preschool | 9 | 2024 | 42063 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2015 | 1248 | 0.080 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2011 | 328 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2012 | 2881 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2017 | 4555 | 0.080 |
Why?
|
| Oogenesis | 1 | 2009 | 124 | 0.080 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2008 | 47 | 0.080 |
Why?
|
| Decision Trees | 2 | 2021 | 506 | 0.080 |
Why?
|
| Paracentesis | 1 | 2008 | 98 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 2332 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2011 | 362 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2315 | 0.080 |
Why?
|
| Feedback | 1 | 2012 | 791 | 0.080 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 58995 | 0.070 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 7806 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 1933 | 0.070 |
Why?
|
| Poverty | 3 | 2024 | 2695 | 0.070 |
Why?
|
| Computer-Assisted Instruction | 1 | 2010 | 362 | 0.070 |
Why?
|
| Genome, Human | 2 | 2018 | 4417 | 0.070 |
Why?
|
| Pandemics | 6 | 2023 | 8624 | 0.070 |
Why?
|
| Fetus | 2 | 2019 | 1859 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 594 | 0.070 |
Why?
|
| Cytokines | 2 | 2023 | 7343 | 0.070 |
Why?
|
| Surgical Mesh | 3 | 2017 | 311 | 0.070 |
Why?
|
| Risk Assessment | 7 | 2020 | 24123 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2009 | 320 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1328 | 0.070 |
Why?
|
| Constipation | 3 | 2019 | 561 | 0.070 |
Why?
|
| Vaginal Diseases | 1 | 2007 | 103 | 0.070 |
Why?
|
| Choice Behavior | 2 | 2024 | 821 | 0.070 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2006 | 19 | 0.070 |
Why?
|
| Urodynamics | 2 | 2019 | 346 | 0.070 |
Why?
|
| Surgical Wound Infection | 2 | 2014 | 1527 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 442 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 614 | 0.070 |
Why?
|
| Models, Educational | 1 | 2008 | 373 | 0.060 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 68 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2008 | 306 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8515 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2017 | 3905 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12531 | 0.060 |
Why?
|
| Factor VIII | 1 | 2007 | 349 | 0.060 |
Why?
|
| Documentation | 1 | 2011 | 893 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2024 | 2326 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5791 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2011 | 707 | 0.060 |
Why?
|
| Tuberculosis | 1 | 2017 | 2001 | 0.060 |
Why?
|
| Pregnancy Tests | 1 | 2024 | 33 | 0.060 |
Why?
|
| Sheep | 2 | 2008 | 1441 | 0.060 |
Why?
|
| Nurses | 1 | 2014 | 2467 | 0.060 |
Why?
|
| Women's Health | 3 | 2024 | 2056 | 0.060 |
Why?
|
| Clinical Clerkship | 1 | 2010 | 563 | 0.060 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 134 | 0.060 |
Why?
|
| Axilla | 2 | 2018 | 626 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 908 | 0.060 |
Why?
|
| Reference Values | 3 | 2007 | 4925 | 0.060 |
Why?
|
| Poisson Distribution | 2 | 2016 | 507 | 0.060 |
Why?
|
| Collagen | 2 | 2003 | 2636 | 0.060 |
Why?
|
| Telemedicine | 1 | 2022 | 3018 | 0.060 |
Why?
|
| CpG Islands | 2 | 2020 | 1221 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2021 | 5508 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 1175 | 0.060 |
Why?
|
| Orgasm | 1 | 2024 | 61 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5961 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 1084 | 0.060 |
Why?
|
| HIV Infections | 2 | 2021 | 17165 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2016 | 555 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 2421 | 0.060 |
Why?
|
| Self Report | 3 | 2020 | 3711 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2007 | 457 | 0.050 |
Why?
|
| Prognosis | 7 | 2021 | 29658 | 0.050 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 579 | 0.050 |
Why?
|
| Soaps | 1 | 2023 | 29 | 0.050 |
Why?
|
| Elbow Joint | 1 | 2007 | 356 | 0.050 |
Why?
|
| Protein S | 1 | 2002 | 30 | 0.050 |
Why?
|
| Gastric Bypass | 1 | 2011 | 829 | 0.050 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 131 | 0.050 |
Why?
|
| Ankle Joint | 1 | 2007 | 435 | 0.050 |
Why?
|
| Mastectomy, Segmental | 2 | 2019 | 972 | 0.050 |
Why?
|
| Sex Education | 2 | 2014 | 92 | 0.050 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 24 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 88 | 0.050 |
Why?
|
| Radiotherapy | 2 | 2020 | 1504 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 1674 | 0.050 |
Why?
|
| Models, Animal | 1 | 2008 | 2117 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5785 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2020 | 12103 | 0.050 |
Why?
|
| Ligaments | 1 | 2022 | 127 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5889 | 0.050 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 15840 | 0.050 |
Why?
|
| Blood Platelets | 2 | 2003 | 2520 | 0.050 |
Why?
|
| Perinatal Mortality | 1 | 2022 | 101 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5425 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 2640 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8594 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 47 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9501 | 0.050 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2001 | 71 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2007 | 968 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2128 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13630 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2194 | 0.050 |
Why?
|
| Infusions, Intravenous | 2 | 2007 | 2234 | 0.050 |
Why?
|
| Synovitis | 1 | 2002 | 215 | 0.050 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2020 | 35 | 0.050 |
Why?
|
| Chickenpox | 1 | 2001 | 97 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11712 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7475 | 0.050 |
Why?
|
| Birth Certificates | 1 | 2020 | 70 | 0.050 |
Why?
|
| Observer Variation | 1 | 2007 | 2601 | 0.040 |
Why?
|
| Postmenopause | 2 | 2022 | 2509 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 2001 | 158 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 257 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2016 | 8035 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2018 | 11152 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1067 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3811 | 0.040 |
Why?
|
| Vitrification | 1 | 2020 | 51 | 0.040 |
Why?
|
| Prescriptions | 1 | 2022 | 388 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2023 | 415 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2686 | 0.040 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2014 | 216 | 0.040 |
Why?
|
| Curriculum | 3 | 2023 | 3718 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2020 | 2985 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2003 | 559 | 0.040 |
Why?
|
| Empathy | 1 | 2024 | 473 | 0.040 |
Why?
|
| Apgar Score | 1 | 2019 | 126 | 0.040 |
Why?
|
| Intention | 1 | 2022 | 345 | 0.040 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 4744 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6315 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 15289 | 0.040 |
Why?
|
| Logistic Models | 4 | 2019 | 13314 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 14660 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 818 | 0.040 |
Why?
|
| Cell Shape | 1 | 2020 | 372 | 0.040 |
Why?
|
| Coronary Circulation | 1 | 2005 | 1577 | 0.040 |
Why?
|
| Probability | 3 | 2012 | 2475 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2005 | 820 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2002 | 534 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 2210 | 0.040 |
Why?
|
| Lactation | 1 | 2021 | 397 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1078 | 0.040 |
Why?
|
| ROC Curve | 2 | 2019 | 3568 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2012 | 5523 | 0.040 |
Why?
|
| Educational Status | 2 | 2017 | 2515 | 0.040 |
Why?
|
| Uterus | 1 | 2022 | 651 | 0.040 |
Why?
|
| Anger | 1 | 2020 | 401 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 780 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 306 | 0.040 |
Why?
|
| Knee Joint | 1 | 2007 | 1663 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 1064 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2018 | 2629 | 0.040 |
Why?
|
| Term Birth | 1 | 2018 | 140 | 0.040 |
Why?
|
| Maternal-Child Health Centers | 1 | 2017 | 42 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2020 | 275 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 746 | 0.040 |
Why?
|
| Hemorrhage | 2 | 2007 | 3600 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12427 | 0.040 |
Why?
|
| Chorionic Villi | 1 | 2017 | 53 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 1400 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1175 | 0.040 |
Why?
|
| Markov Chains | 1 | 2021 | 968 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2017 | 147 | 0.040 |
Why?
|
| Access to Information | 1 | 2020 | 320 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 370 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 12159 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2672 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2020 | 3528 | 0.040 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2016 | 30 | 0.040 |
Why?
|
| Comprehension | 2 | 2012 | 618 | 0.030 |
Why?
|
| Laparotomy | 1 | 2019 | 465 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2021 | 510 | 0.030 |
Why?
|
| Israel | 1 | 2019 | 722 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 635 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2020 | 553 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2001 | 1173 | 0.030 |
Why?
|
| Vaginal Discharge | 1 | 2016 | 26 | 0.030 |
Why?
|
| Nocturia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 9467 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 552 | 0.030 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 128 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2015 | 86 | 0.030 |
Why?
|
| Health Literacy | 1 | 2020 | 440 | 0.030 |
Why?
|
| Hair | 1 | 2018 | 497 | 0.030 |
Why?
|
| Epigenomics | 1 | 2020 | 936 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2018 | 506 | 0.030 |
Why?
|
| Medicare | 2 | 2023 | 6786 | 0.030 |
Why?
|
| Sudan | 1 | 2014 | 86 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 700 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2016 | 188 | 0.030 |
Why?
|
| Uterine Hemorrhage | 1 | 2016 | 242 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2018 | 624 | 0.030 |
Why?
|
| Medical Staff | 1 | 2014 | 40 | 0.030 |
Why?
|
| Parturition | 1 | 2018 | 446 | 0.030 |
Why?
|
| World Health Organization | 1 | 2020 | 1312 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1765 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1348 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 713 | 0.030 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 3388 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10181 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 725 | 0.030 |
Why?
|
| Quality of Life | 3 | 2023 | 13308 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2013 | 87 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2020 | 878 | 0.030 |
Why?
|
| New York | 1 | 2016 | 875 | 0.030 |
Why?
|
| Midwifery | 1 | 2015 | 122 | 0.030 |
Why?
|
| Constriction | 1 | 2013 | 172 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2128 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 8651 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7850 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2014 | 190 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 14495 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 987 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2001 | 2118 | 0.030 |
Why?
|
| Spouses | 1 | 2015 | 279 | 0.030 |
Why?
|
| Pregnancy in Adolescence | 1 | 2014 | 162 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2003 | 4000 | 0.030 |
Why?
|
| Cystocele | 1 | 2012 | 5 | 0.030 |
Why?
|
| Sutures | 1 | 2014 | 293 | 0.030 |
Why?
|
| Students | 1 | 2022 | 1730 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 1441 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2013 | 177 | 0.030 |
Why?
|
| Population Surveillance | 2 | 2014 | 2608 | 0.030 |
Why?
|
| Bromocriptine | 1 | 2012 | 93 | 0.030 |
Why?
|
| Rectocele | 1 | 2012 | 21 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 553 | 0.020 |
Why?
|
| Leiomyoma | 1 | 2017 | 654 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2018 | 1895 | 0.020 |
Why?
|
| Linear Models | 2 | 2017 | 5877 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 464 | 0.020 |
Why?
|
| Hematocrit | 1 | 2013 | 629 | 0.020 |
Why?
|
| Research Design | 2 | 2020 | 6180 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 2053 | 0.020 |
Why?
|
| Hernia | 1 | 2012 | 68 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2015 | 491 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2011 | 399 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 1791 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 422 | 0.020 |
Why?
|
| Individuality | 1 | 2012 | 300 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4291 | 0.020 |
Why?
|
| Birth Injuries | 1 | 2012 | 150 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1677 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 696 | 0.020 |
Why?
|
| Brachial Plexus | 1 | 2012 | 166 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2282 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2014 | 765 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2022 | 12766 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1356 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6498 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 2943 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1809 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6544 | 0.020 |
Why?
|
| Estradiol | 1 | 2017 | 1932 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 926 | 0.020 |
Why?
|
| Neural Tube Defects | 1 | 2012 | 254 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1186 | 0.020 |
Why?
|
| Disease Progression | 1 | 2007 | 13502 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3618 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3465 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1650 | 0.020 |
Why?
|
| Mastectomy | 1 | 2018 | 1832 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 409 | 0.020 |
Why?
|
| Platelet Aggregation | 2 | 2003 | 805 | 0.020 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 6 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4351 | 0.020 |
Why?
|
| Platelet Activation | 2 | 2003 | 660 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 3075 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2021 | 2064 | 0.020 |
Why?
|
| Patient Participation | 1 | 2018 | 1439 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 428 | 0.020 |
Why?
|
| Medicaid | 1 | 2022 | 2815 | 0.020 |
Why?
|
| Biopsy | 1 | 2020 | 6771 | 0.020 |
Why?
|
| California | 1 | 2013 | 1416 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8482 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6360 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 5990 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 2477 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 2628 | 0.020 |
Why?
|
| Community Health Services | 1 | 2013 | 654 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2017 | 2256 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3529 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2013 | 628 | 0.020 |
Why?
|
| Prolapse | 1 | 2007 | 63 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2012 | 551 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2554 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2008 | 162 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 2659 | 0.020 |
Why?
|
| Workflow | 1 | 2011 | 852 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2186 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 599 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 1206 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3817 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 321 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3527 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 36290 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 1407 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 5066 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20080 | 0.020 |
Why?
|
| Minority Groups | 1 | 2013 | 1201 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2007 | 568 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6659 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1336 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 1425 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15757 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2008 | 682 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3726 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9411 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8552 | 0.010 |
Why?
|
| Ovary | 1 | 2008 | 958 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 2963 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1736 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 29932 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10344 | 0.010 |
Why?
|
| Internal Medicine | 1 | 2011 | 1048 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4902 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 306 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1657 | 0.010 |
Why?
|
| Forecasting | 1 | 2012 | 2932 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2002 | 100 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 116 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1120 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2012 | 2860 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 575 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11481 | 0.010 |
Why?
|
| Elbow | 1 | 2002 | 130 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2011 | 2086 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5201 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12808 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1755 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 2660 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8469 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2192 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1764 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10182 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18137 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3484 | 0.010 |
Why?
|
| Knee | 1 | 2002 | 276 | 0.010 |
Why?
|
| Animals | 4 | 2021 | 167963 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 1287 | 0.010 |
Why?
|
| Outpatients | 1 | 2008 | 1607 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3520 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1941 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 1516 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2005 | 488 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3925 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2016 | 4647 | 0.010 |
Why?
|
| Ankle | 1 | 2002 | 350 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4899 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 6048 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6015 | 0.010 |
Why?
|
| Heart | 1 | 2012 | 4393 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2002 | 926 | 0.010 |
Why?
|
| Chest Pain | 1 | 2005 | 1106 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4354 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14372 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10827 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1157 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2362 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6218 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 2164 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2005 | 4563 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5870 | 0.010 |
Why?
|
| Contrast Media | 1 | 2005 | 5305 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 8525 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 81208 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 11891 | 0.000 |
Why?
|
| Stroke | 1 | 2002 | 9962 | 0.000 |
Why?
|